Research-grade compound. Laboratory use only. Not intended for human or animal use, ingestion, or injection. No medical claims are made or implied.
≥98% PuritySupplier batch spec · ≥98% (class spec)
Growth Factor Research PeptidesSKU: CP-TI18
Tesamorelin + Ipamorelin Blend 18mg
≥98% PuritySupplier batch spec; selected lots Janoshik-tested
€73.49In Stock
Delivers to EU in 11-14 business days
Free shipping over €200 · no customs paperwork (EU) · via EU carrier network
Research-grade Tesamorelin + Ipamorelin Blend. Each vial contains 9mg Tesamorelin + 9mg Ipamorelin (1:1 ratio, 18mg total). ≥ 98% supplier batch specification; selected lots independently tested (99.3% avg across published reports). Lyophilized powder in sealed glass vial. For laboratory research use only. Not for human consumption.
Volume PricingApplied automatically at checkout
| Quantity | Price Each | Total | Savings |
|---|---|---|---|
| 1 unit | €73.49 | €73.49 | -- |
| 3+ | €69.82 | €209.45 | 5% off |
| 5+Most Popular | €66.14 | €330.70 | 10% off |
| 10+ | €62.47 | €624.67 | 15% off |
1
Total: €73.49
Free shipping on orders over €200
Important Notice
This product is intended for laboratory and research use only. Not for human or veterinary use. By purchasing, you confirm this product will be used exclusively for in-vitro research purposes.
Reconstitution Required
This peptide ships lyophilized (dry powder) and requires bacteriostatic water to reconstitute before use. BAC water is sold separately.
When This Product May Not Suit Your Research
- ⚠If your research requires GMP-grade material for clinical applications — research-grade peptides are not intended for clinical use.
- ⚠If your lab lacks proper cold storage (-20°C freezer) — this peptide's stability may be compromised at higher temperatures.
- ⚠If your study protocol requires FDA-approved reference standards — contact USP or a certified reference material provider.
Purity HPLC
99.3% average HPLC purity, verified by independent third-party testing
Third-Party Tested
Janoshik report published when available
Fast Shipping
24h dispatch, EU-wide shipping from €4.99
Third-Party Tested
Supplier batch specification on every product; independent Janoshik report on selected lots
Last reviewed: 2026-06-07
About Tesamorelin + Ipamorelin Blend 18mg
Tesamorelin + Ipamorelin Blend combines a GHRH analogue with a selective GH secretagogue, targeting two points in the growth hormone axis simultaneously. In research models, Tesamorelin provides the GHRH signal studied for pituitary GH release; Ipamorelin provides ghrelin-mimetic stimulation through GHSR-1a. Each vial contains 9mg of each peptide (18mg total). The combination is designed to produce more robust and physiological GH stimulation than either peptide alone.
Tesamorelin is a synthetic analogue of GHRH (growth hormone-releasing hormone). It is one of very few peptides in this catalog with an established characterization in the published literature, which provides well-defined pharmacology data useful for research context. In research models, Tesamorelin is studied for stimulating pulsatile GH release by binding pituitary GHRH receptors, with the natural pulsatility of GH secretion preserved rather than producing a continuous elevation.
Ipamorelin is a highly selective GHRP that activates GHSR-1a with minimal effect on cortisol and prolactin -- side effects common with earlier GHRPs like GHRP-2 and GHRP-6. This selectivity makes it the preferred GHRP for combination research where clean GH stimulation without hormonal side effects is the goal. The GHRH + GHRP combination works through complementary mechanisms and is generally more effective than either alone in preclinical research.
Research Applications
Used in research on growth hormone axis pharmacology, body composition (lean mass and fat distribution) in models, lipid metabolism, sleep architecture (GH has roles in sleep biology), and aging-related hormonal decline. The combination is well-suited for studies seeking physiological GH stimulation patterns.
Specifications
| Parameter | Value |
|---|---|
| Component 1 | Tesamorelin 9mg (GHRH analogue) |
| Component 2 | Ipamorelin 9mg (selective GHRP) |
| Total per Vial | 18mg combined |
| Purity | ≥98% (supplier batch spec; 99.3% avg across independently tested lots, each component) |
| Format | Lyophilized powder, single-use vial |
| Storage | -20°C before reconstitution; 2-8°C after |
Storage
Store at -20°C before reconstitution. Refrigerate at 2-8°C after reconstitution and use within 28 days. Avoid freeze-thaw cycles after reconstitution.
Why combine GHRH and a GHRP rather than use either alone?
GHRH and GHRPs work through complementary mechanisms: GHRH directly stimulates pituitary somatotrophs via its receptor, while GHRPs act through GHSR-1a (the ghrelin receptor) which amplifies the GHRH response through a different signaling pathway. Research consistently shows that combining GHRH with a GHRP produces substantially greater GH release than either alone -- the combination is synergistic rather than merely additive. This synergy is why combination protocols are used in preclinical studies seeking robust GH stimulation.
What is unique about Tesamorelin compared to other GHRH analogues?
Tesamorelin is a stabilized analogue of GHRH(1-44) modified with a trans-3-hexenoic acid group that increases half-life. It also has an unusually well-developed pharmacology dataset compared to most research peptides in its class, which typically lack extensive characterization. That well-defined pharmacology and dose-response data provide useful context for preclinical research.
Why is Ipamorelin preferred over other GHRPs in combination research?
Ipamorelin has high selectivity for GHSR-1a with minimal action on receptors that mediate cortisol and prolactin release. Earlier GHRPs like GHRP-2 and GHRP-6 produce cortisol and prolactin elevation alongside GH stimulation, which complicates research endpoints and adds confounding variables. Ipamorelin's cleaner profile makes it the preferred choice when the research goal is GH stimulation specifically, without concurrent stress hormone activation that could independently affect body composition or immune parameters in models.
Tesamorelin + Ipamorelin Blend is supplied for laboratory research use only. Not approved for human use. Handle in compliance with institutional biosafety guidelines.
Specification Summary
Purity99.3% avg
FormLyophilized Powder
Storage-20\u00B0C
Researcher Confidence
Why researchers choose CertaPeptides
Who actually tests this?
Selected lots are independently verified by Janoshik Analytical (Czech Republic) and published on the Janoshik public portal. Other lots ship with the supplier's batch specification. See /coa for the published wall.
View COAs →What if I get the wrong batch?
Every bottle label carries a lot number that maps to a specific Certificate of Analysis. If a batch fails spec, we don't ship it — full stop.
View COAs →Where does it ship from?
Romania (EU). We are CERTALAB SRL, CUI 54169956, VAT-registered. Sameday for Romania, TCE Worldwide for all cross-border EU and non-EU markets (UK, Switzerland, Norway, Iceland, Israel, Serbia). Delivery 1–14 business days depending on destination — exact window shown at checkout.
Shipping details →What if there's a problem?
You have a 14-day withdrawal right under OUG 34/2014 (Romanian/EU consumer law), with ANPC/ODR escalation available. Contact us at support@certapeptides.com.
Returns policy →Product Information
This product is intended for scientific research and development purposes only. It is a chemical substance that shall not be used as a drug, medicine, active substance, or ingredient in any product intended for human or animal consumption. Researchers must handle this compound in accordance with their institutional biosafety guidelines. Use only in properly equipped laboratory settings with appropriate personal protective equipment.
Frequently Asked
Research Library
Related Research Articles
Based on category & popularity
Researchers Also Studied
SAME FIELDGrowth Factor Research Peptides
IGF-1LR3
IGF-1 LR3 (Long Arg3 IGF-1) is an 83-amino acid analog of insulin-like growth factor 1 with an arginine substitution at position 3 and a 13-amino acid N-terminal extension. These modifications significantly reduce IGF binding protein affinity, increasing bioavailability in research applications. Extended analog of IGF-1 with enhanced bioavailability Muscle hypertrophy and tissue growth studies IGF-1 signaling pathway and receptor activation research For research purposes only.
From€21.99
1mgSAME FIELDGrowth Factor Research Peptides
Follistatin 344 1mg
Research-grade Follistatin 344. ≥98% (supplier batch specification); selected lots independently tested by Janoshik (HPLC + mass spectrometry), searchable at certapeptides.com/verify. Lyophilized powder in sealed glass vial. For laboratory research use only. Not for human consumption.
€118.99
SAME FIELDGrowth Factor Research Peptides
AOD-9604
Research-grade AOD-9604. ≥98% supplier batch specification; selected lots independently tested (99.3% avg across published reports). Lyophilized powder in sealed glass vial. For laboratory research use only. Not for human consumption.
From€94.99
RESEARCHERS ALSO STUDIEDEndocrine and Hormone Research Peptides
CJC-1295 Without DAC
Research-grade CJC-1295 Without DAC. ≥98% supplier batch specification; selected lots independently tested (99.3% avg across published reports). Lyophilized powder in sealed glass vial.
From€29.99
Frequently researched together
Tesamorelin + Ipamorelin Blend 18mg€73.49
1